AstraZeneca and Daiichi Sankyo received FDA approval for Enhertu in early-stage HER2-positive breast cancer in both ...

AstraZeneca Plc’s market value surged above £200 billion ($257 billion) for the first time after a big bet on cancer drugs helped drive a rally in the shares. Shares climbed as much as 0.5% on ...

AstraZeneca (LSE:AZN) received US FDA approval for IMFINZI (durvalumab) with BCG therapy in BCG naïve, high risk non muscle invasive bladder cancer, based on positive Phase III data showing a ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Wondering if AstraZeneca at £137.48 is offering fair value ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

For monetary values the unit of change is percent; for Gross Margin, Operating Margin and Tax rate the unit of change is percentage points. In the expense commentary above, the plus and minus symbols ...

We are holding steady to our AstraZeneca fair value estimate following an investor day, which highlighted 2030 sales guidance of $80 billion and 2026 core operating margins of mid-30s. While we ...

Early this morning, AstraZeneca shared the results of a phase 3 clinical trial of baxdrostat, its investigational drug for treatment-resistant hypertension (i.e., high blood pressure). The company ...

For dollar values in this table, the unit of change is percent. For Gross Margin, Operating Margin and Tax rate, the unit of change is percentage points (pp). In the table above, R&D expense, SG&A ...